Despite progress in understanding the pathophysiology of human cytomegalovirus (HCMV) infections, its manifestations in the immune compromised host are frequently associated with high morbidity and mortality. In this setting, HCMV disease can develop e.g. following immune suppression as a result of reactivation of latent HCMV acquired earlier in life (1;2). The mechanisms leading to establishment of latent infections and their subsequent reactivation are not clear. It is also unknown whether HCMV exists in a latent form with limited viral gene expression or as a persistent infection with normal virus transcription. We propose to investigate the relationship between HCMV and bone marrow progenitor cells to understand whether HCMV is latent in CD34 + bone marrow progenitors and the mechanism by which the virus remains in a latent state. This overall goal will be pursued as follows. 1) Determine the percentage of HCMV positive donors whose bone marrow progenitors contain HCMV DNA using nested PCR and determine if virus can be rescued from those cells. 2) Analysis of the HCMV life cycle in hematopoietic progenitor and stem cells. 3) Identification and analysis of HCMV gene expression in in vivo infected leukocytes. Bone marrow progenitors containing HCMV DNA detectable by nested PCR will be isolated from human donors and used as as source of mRNA to prepare Cdna libraries. 4) Determine if gene(s) expressed in bone marrow progenitors are important in either establishing or maintaining a latent infection or in the lytic cycle of HCMV. Information provided from the above studies will yield information that will be important in planning future approaches for the therapy of HCMV infections.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL063470-04
Application #
6537690
Study Section
Hematology Subcommittee 2 (HEM)
Program Officer
Barbosa, Luiz H
Project Start
1999-07-01
Project End
2004-06-30
Budget Start
2002-07-01
Budget End
2004-06-30
Support Year
4
Fiscal Year
2002
Total Cost
$243,489
Indirect Cost
Name
University of Nevada Reno
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
146515460
City
Reno
State
NV
Country
United States
Zip Code
89557
Keyes, Lisa R; Bego, Mariana G; Soland, Melisa et al. (2012) Cyclophilin A is required for efficient human cytomegalovirus DNA replication and reactivation. J Gen Virol 93:722-32
Keyes, Lisa R; Hargett, Danna; Soland, Melisa et al. (2012) HCMV protein LUNA is required for viral reactivation from latently infected primary CD14? cells. PLoS One 7:e52827
Bego, Mariana G; Keyes, Lisa R; Maciejewski, Jarek et al. (2011) Human cytomegalovirus latency-associated protein LUNA is expressed during HCMV infections in vivo. Arch Virol 156:1847-51
Rizvanov, Albert A; Khaiboullina, Svetlana F; van Geelen, Albert G M et al. (2006) Replication and immunoactivity of the recombinant Peromyscus maniculatus cytomegalovirus expressing hantavirus G1 glycoprotein in vivo and in vitro. Vaccine 24:327-34
Deyde, Varough M; Rizvanov, Albert A; Chase, Jessica et al. (2005) Interactions and trafficking of Andes and Sin Nombre Hantavirus glycoproteins G1 and G2. Virology 331:307-15
Bego, Mariana; Maciejewski, J; Khaiboullina, S et al. (2005) Characterization of an antisense transcript spanning the UL81-82 locus of human cytomegalovirus. J Virol 79:11022-34
Khaiboullina, Svetlana F; Maciejewski, Jaroslaw P; Crapnell, Kirsten et al. (2004) Human cytomegalovirus persists in myeloid progenitors and is passed to the myeloid progeny in a latent form. Br J Haematol 126:410-7
Rizvanov, Albert A; van Geelen, Albert G M; Morzunov, Sergey et al. (2003) Generation of a recombinant cytomegalovirus for expression of a hantavirus glycoprotein. J Virol 77:12203-10
Crapnell, K; Zanjani, E D; Chaudhuri, A et al. (2000) In vitro infection of megakaryocytes and their precursors by human cytomegalovirus. Blood 95:487-93